Bristol Myers Squibb Opens New Pharmaceutical Manufacturing Campus in Houston
Bristol Myers Squibb is opening a new pharmaceutical manufacturing campus in the Houston area.
Houston, TX, August 10, 2026 —
Bristol Myers Squibb, a global biopharmaceutical company, has announced the opening of a new pharmaceutical manufacturing campus located in the Houston area.
The new facility is expected to enhance the company’s manufacturing capabilities and contribute to its global supply chain for vital medicines.
Further details regarding the specific size of the campus, the investment involved, the number of jobs created, and the timeline for full operational capacity were not immediately available.
This expansion into the Houston area marks a significant development for Bristol Myers Squibb as it continues to grow its operational footprint. The company focuses on developing and delivering innovative medicines that help patients prevail over serious diseases.
The strategic placement of this new campus in Houston aims to leverage the region’s resources and infrastructure to support the production and distribution of pharmaceuticals.
The specific types of pharmaceuticals to be manufactured at the new campus and their target markets have not been disclosed at this time.
Story summarized from the original created by Google News on news.google.com, see more information here.
